Results 121 to 130 of about 72,198 (215)

Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries. [PDF]

open access: yesFront Pharmacol
Zhang L   +11 more
europepmc   +1 more source

Treatment‐free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations

open access: yes
British Journal of Haematology, EarlyView.
Simone Claudiani   +6 more
wiley   +1 more source

Social bees can enhance the persistence of plant–bee interactions during seasonal changes in seasonally dry tropical forests

open access: yesEcological Entomology, EarlyView.
Social bees, especially Meliponini, formed a persistent core that maintained plant–bee interactions across both dry and green seasons in the Caatinga. Persistence was not linked to broader diets; social bees used fewer plant species, despite availability, indicating selective tracking of temporally concentrated floral resources.
Ana Letícia S. Lima   +3 more
wiley   +1 more source

Oxidative Phosphorylation and Fatty Acid Oxidation Are Central to Mitochondrial Metabolism Rewiring in CML Stem/Progenitor Cell Survival. [PDF]

open access: yesPathophysiology
Milenkovic J   +6 more
europepmc   +1 more source

Independent validation of the International Metabolic Prognostic Index (CAR‐IMPI) in patients with aggressive diffuse large B‐cell lymphoma treated with CAR‐T

open access: yes
British Journal of Haematology, EarlyView.
Eugenio Galli   +11 more
wiley   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto   +12 more
wiley   +1 more source

HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR

open access: yesJournal of Blood Medicine
Ikhwan Rinaldi,1,2 Radinal Mauludi,2 Sri Widia Jusman,3 Robert Sinto,4 Kuntjoro Harimurti5,6 1Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas ...
Rinaldi I   +4 more
doaj  

Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia. [PDF]

open access: yesHemasphere
Pagani IS   +25 more
europepmc   +1 more source

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy